# Construction of a management protocol for high-risk neurogenic bladder in Chinese patients with type 2 diabetes: a Delphi study

**Authors:** Senying Luo, Wei Ren, YingJie Hu, Ting Deng, Wenjuan Lai, Wenzhi Cai

PMC · DOI: 10.3389/fendo.2025.1603905 · Frontiers in Endocrinology · 2025-10-17

## TL;DR

This study created a new protocol to manage high-risk neurogenic bladder in Chinese patients with type 2 diabetes using expert consensus and evidence-based indicators.

## Contribution

The study introduces China’s first hierarchical risk stratification system for neurogenic bladder in type 2 diabetes patients.

## Key findings

- A three-tiered protocol was developed with 4 primary, 17 secondary, and 60 tertiary indicators.
- Expert consensus improved significantly across two Delphi rounds, with primary indicators showing the highest improvement.
- The protocol integrates policy, clinical algorithms, and bedside assessments to improve patient outcomes.

## Abstract

The objective of this study is to establish an evidence-based protocol for managing high-risk neurogenic bladder (NB) in Chinese patients with T2DM, integrating risk stratification to standardize clinical practice in China region.

Through a two-round Delphi consensus process involving 20 national experts and evidence synthesis from 13 clinical guidelines and a systematic review, we developed China’s first hierarchical NB risk stratification system. Quantitative analyses incorporated authority weighting (0–1 scale), coordination coefficients, and Kendall’s concordance testing across 81 systematically validated clinical indicators.

High expert engagement persisted through both rounds (Round 1: 90% response rate; Round 2: 94.7%). Consensus levels demonstrated progressive improvement, with primary indicators achieving the most substantial enhancement (Kendall’s W: 0.289 vs. 0.391, 35.3% improvement). Secondary and tertiary indicators showed 5.5% and 27.4% increases respectively (all p<0.01). The final protocol reached a consensus, including 4 primary indicators, 17 secondary indicators, and 60 tertiary indicators.

This consensus-driven framework provides innovative clinical tools for NB risk stratification in diabetes care. Its three-tiered structure—integrating policy recommendations, clinical algorithms, and bedside assessment protocols—significantly improves patient management and outcomes, serving as a valuable resource to guide clinical practice.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), neurogenic bladder (MONDO:0001445)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), type 2 diabetes (MESH:D003924), NB (MESH:D001750)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12541250/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12541250/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12541250/full.md

---
Source: https://tomesphere.com/paper/PMC12541250